Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | H3B-8800 |
Synonyms | |
Therapy Description |
H3B-8800 binds to the SF3B complex and modulates splicing events, potentially resulting in killing of tumor cells harboring splicesome mutations (PMID: 29457796, PMID: 31902291). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
H3B-8800 | H3B 8800 | H3B-8800 binds to the SF3B complex and modulates splicing events, potentially resulting in killing of tumor cells harboring splicesome mutations (PMID: 29457796, PMID: 31902291). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02841540 | Phase I | H3B-8800 | A Phase 1 Study to Evaluate H3B-8800 in Participants With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia | Terminated | USA | ITA | FRA | ESP | BEL | 2 |